Business
Kratos wins $100 million sole-source space surveillance contract
Kratos received an approximate $100 million sole-source prime award for a ground-based space domain awareness system, adding to its defense backlog.
Eli Lilly agreed to buy AtaiBeckley for $2.8 billion upfront plus up to $1.0 billion in milestones, adding psychedelic depression assets to its pipeline.
Novartis will buy UK biotech Myricx Bio for $1.1 billion upfront plus up to $400 million in milestones to expand its targeted cancer therapy pipeline.
United Therapeutics will acquire Thymmune for $140 million upfront plus up to $160 million in milestones, adding a preclinical thymic cell therapy platform.